Wednesday, May 24, 2006

Samsung Prepping Hybrid Hard Drives

Samsung plans to demonstrate prototype flash-and-hard-disk hybrids next week at WinHEC, aiming to improve start/resume times and extend laptop battery life.

Samsung Electronics has found another use for all that flash memory it’s manufacturing: packing it into hard drives. At next week’s WinHEC 2006conference, Samsung plans to demonstrate new Hybrid Hard Disk (HHD) storage devices, which combine a conventional magnetic platter storage with NAND flash memory.

The basic idea is that each hard disk has a cache of 128 or 256 MB of flash memory, with the idea of improving startup and resume times for notebook computers and other portable electronic devices which require hard disk storage, while simultaneously extending battery life by reducing the amount of time hard disks spin up to access data. When the flash-base drive cache is filled, the system spins up its hard disk to flush data to magnetic storage: the result is a disk which spins up for a few seconds every 10 or 20 minutes, rather than a disk which spins more-or-less continually during active use. Furthermore, the speed of flash memory means users should not see delays or lags when material is written to cache or flushed to disk.


So that means other alternative drives are coming?

posted by nattietodd @ 12:19 PM 0 Comments

Indian Firm Received Tramadol License

From Business Standard:
Ranbaxy Laboratories has announced a strategic in-licensing agreement for the Indian market, with Ethypharm LL India, a wholly-owned subsidiary of a French drug delivery firm, for the Novel Drug Delivery System (NDDS) analgesic, Tramadol 50 mg Flashtab.

According to an official release issued by Ranbaxy to the BSE today, the product will be supplied from Ethypharm's manufacturing facility near Mumbai, and marketed and distributed by Ranbaxy under the brand name 'Trambax'.

"The introduction of Trambax (Tramadol Flashtab®) Tablets is part of Ranbaxy's strategy to provide world-class products with NDDS technology to doctors in India bringing rapid pain relief to their patients. This will further strengthen our portfolio in the pain management segment,"Sanjeev I Dani, regional director (India and Middle East) of Ranbaxy, said.

Tramadol for pain relief is a drug of choice for severe to moderately severe pain in trauma cases and is currently one of the four most commonly prescribed analgesics worldwide. It is also used as an adjunct therapy in the treatment of cancer patients, the release said.

posted by nattietodd @ 8:43 AM 0 Comments